The Employers’ Prescription for Affordable Drugs (EmployersRx) supports policies that would require PBMs to make pricing data available to payers and compel drug companies to report and justify price increases for some medications. EmployersRx also seeks to strengthen competition and remove barriers that stifle the development and use of generic drugs and biosimilars.
Mobilizing large employers to drive down drug costs by educating and influencing public policies
Built on the tenets of transparency, competition, and value, EmployersRx supports public policies that drive down the cost of drugs while preserving true innovation as part of a value-based health care system. Led by the Purchaser Business Group on Health, the National Alliance is one of six industry leaders that form the EmployersRx coalition.
Over the past decade, the cost of prescription drugs has increased three times faster than the rate of inflation. These resources support efforts by large employers to advocate for public policies based on increased competition, transparency and value.
EmployersRx Policy Objectives
Coalitions In Action
Membership in the National Alliance is a catalyst for state and regional coalitions and their employer/purchaser members to advance key initiatives. Together, they leverage their collective influence to drive health, equity and value.
Purchaser Business Group on Health
To reduce healthcare costs and improve access to higher quality care, PBGH helps purchasers disrupt the complicated and opaque pharmaceutical supply chain and hold vendors accountable. The result is transformative benefit design and access to better and more transparent drug pricing for employers and their employees.